- Published at
- by manilatimes.net
positive
positive
News for G1 Therapeutics, Inc. (GTHX)
- Published at
- by globenewswire.com
neutralneutralPharmacosmos Group and G1 Therapeutics Announce Expiration of Hart-Scott-Rodino Waiting Period
Pharmacosmos Group and G1 Therapeutics Announce Expiration of Hart-Scott-Rodino Waiting Period...- Published at
- by investing.com
mixedmixedGTHX Stock Soars to 52-Week High, Reaching $7.12 Amidst 313% Annual Surge By Investing.com
GTHX Stock Soars to 52-Week High, Reaching $7.12 Amidst 313% Annual Surge- Published at
- by investing.com
positivepositiveGTHX stock soars to 52-week high, hits $7.1 amid growth By Investing.com
GTHX stock soars to 52-week high, hits $7.1 amid growth- Published at
- by globenewswire.com
positivepositiveSHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates GVP, PETQ, GTHX on Behalf of Shareholders
NEW YORK, Aug. 15, 2024 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential...- Published at
- by globenewswire.com
positivepositiveBRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Thoughtworks Holding, Inc. (Nasdaq – TWKS), PetIQ, Inc. (Nasdaq – PETQ), G1 Therapeutics, Inc. (Nasdaq – GTHX),
BALA CYNWYD, Pa., Aug. 15, 2024 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to...- Published at
- by rttnews.com
mixedmixedWeekly Review: ANTX Downsizes, ALDX Aces Dry Eye Disease Trial, FDA Oks 1st Epinephrine Nasal Spray
The week saw FDA reprimanding a pharma giant for making false and misleading claims about its non-small cell lung cancer drug and a developer of MDMA therapy for PTSD facing a major setback.- Published at
- by globenewswire.com
positivepositiveGTHX SHAREHOLDER ALERT: The M&A Class Action Firm Investigates the Tender Offer of G1 Therapeutics, Inc.
NEW YORK, Aug. 09, 2024 (GLOBE NEWSWIRE) -- Monteverde & Associates PC (the “M&A Class Action Firm”), has recovered money for shareholders and is...- Published at
- by globenewswire.com
mixedmixedSHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates GTHX, PETQ on Behalf of Shareholders
NEW YORK, Aug. 09, 2024 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential...- Published at
- by zacks.com
positivepositiveG1 Therapeutics (GTHX) Reports Q2 Loss, Tops Revenue Estimates
G1 Therapeutics (GTHX) delivered earnings and revenue surprises of 41.18% and 4.23%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?- Published at
- by seekingalpha.com
neutralneutralG1 Therapeutics GAAP EPS of -$0.10 beats by $0.07, revenue of $16.55M beats by $0.52M (NASDAQ:GTHX)
G1 Therapeutics (GTHX) reported Q2 beats in GAAP EPS and revenue, reaffirmed 2024 revenue guidance, and expects operational expenses to be lower.- Published at
- by benzinga.com
mixedmixedDow Tumbles Over 200 Points; CVS Health Cuts Profit Forecast - CVS Health (NYSE:CVS)
U.S. stocks turned lower toward the end of trading, with the Dow Jones index dipping more than 200 points on Wednesday. The Dow traded down 0.55% to 38,784.80 ...- Published at
- by benzinga.com
mixedmixedCrude Oil Jumps Over 3%; Upstart Shares Spike Higher - PetIQ (NASDAQ:PETQ), G1 Therapeutics (NASDAQ:GTHX)
U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining around 250 points on Wednesday. The Dow traded up 0.95% to 39,367.42 while ...- Published at
- by benzinga.com
mixedmixedNasdaq Jumps 250 Points; Disney Earnings Beat Estimates - Walt Disney (NYSE:DIS)
U.S. stocks traded higher this morning, with the Dow Jones index gaining around 1% on Wednesday. The Dow traded up 0.96% to 39,372.63 while the NASDAQ rose 1.5...- Published at
- by rttnews.com
mixedmixedPre-market Movers: SCPX, GTHX, TLIS, ZCMD, EBS…
North Carolina-based Scorpius Holdings, Inc. (SCPX) is down over 79 percent in Wednesday's pre-market trading. The following are some of the other stocks making big moves in Wednesday's pre-market trading.- Published at
- by marketscreener.com
mixedmixedTScan Therapeutics Announces Updates to its Board of Directors
Garry A. Nicholson, an experienced executive with regulatory and commercial expertise, joins the Board of Directors Timothy Barberich retires as Chair; Stephen Biggar, M.D., Ph.D. assumes the role...- Published at
- by benzinga.com
mixedmixedWhy Applied DNA Sciences Shares Are Trading Lower By Around 68%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session - Applied DNA Sciences (NASDAQ:APDN)
Loading... Loading... Shares of Applied DNA Sciences, Inc. APDN fell sharply during Tuesday's session after the company announced the pricing of a $12 million ...- Published at
- by globenewswire.com
mixedmixedBladder Cancer Clinical Trial Pipeline Experiences Momentum: DelveInsight Estimates a Diverse Pipeline Comprising 70+ Companies Working in the Domain
Bladder cancer, marked by abnormal cell growth in the bladder lining, presents a global health concern. The incidence of bladder cancer is on the rise due...- Published at
- by benzinga.com
mixedmixedWhy IPG Photonics Shares Are Trading Lower By Around 11%? Here Are Other Stocks Moving In Tuesday’s Mid-Day Session - IPG Photonics (NASDAQ:IPGP)
Shares of IPG Photonics Corporation (NASDAQ: IPGP) fell sharply during Tuesday’s session after the company reported mixed fourth-quarter financial results and issued soft first-quarter guidance.WCC-PAWCCVFP.DEVFCO34.SAVFC.MXVFCTWOUTRIP.MXTRIP.BATRIPT6A.DESSRM.TOSSRMSSR.AXSPWRSIENSBFMLRMRJHX.AXJHXJHIUFJBLU.MXJBLUJAW.DEJANIPGP.MXIPGPHTZZHTZGQHTZHRI.MXHRIGTR.DEGT.SWGT.MXGTFREEWFREEFAMIDLACDS.DECDNS.MXCDNSBRKR.MXBRKRBEASPNANET.MXANET0VGE.L0R30.L0R0V.L0QZS.L0QLL.L0LHP.L0JOT.L0J86.L0J4Z.L0J4L.L0HS2.L0HHR.L0A4L.LZIDBGIBIOLBHFAPBHFAOBHFANBHF.MXBHFALT1.MXALT0IJU.L0HPH.L0A4C.LTDCQFTA-UNQFTANSTGGTHXECL.MXECLCAR.MXCAR.BACARBLKB0LEE.L0IFA.L0HK4.L- Published at
- by rttnews.com
mixedmixed